Scalp Flap Transfer in BR
Scalp Flap Transfer in BR section, includes general infrmation about Scalp Flap Transfer Procedure, Scalp Flap Transfer BR Local News, Scalp Flap Transfer BR Surgeon Locator and other Scalp Flap Transfer related material.
Scalp Flap Transfer Procedure
Several medical conditions can produce baldness, such as illness, poor nutrition and thyroid imbalance. Most baldness is not caused by illness, but is an inherited trait.
Bald men with vertex (crown of the head) balding may benefit substantially from scalp flap transfer, with proper preoperative planning, and when the procedure is performed by a skilled, experienced physician hair restoration specialist.
Scalp flap transfer is a technique that involves the transfer of large strips of hair-bearing scalp on the sides of the head (located above the ears) to an area of scalp without hair. The size and placement of the flap will be as per the patient’s needs. The area from which it is removed is closed with stitches. The scar left after the operation will be hidden by the relocated hair. The hair transferred to the new location continues to grow at the same rate and with the same density as the original location. It is the most efficient way to move the greatest amount of hair in the shortest period of time.
Scalp flap transfer aims to repair a non-traumatic cosmetic defect. It also repairs a traumatic injury site and restores its functionality and cosmetic appearance. Another objective of scalp flap surgery is repairing a skin defect resulted by congenital malformation.
Cosmetic and reconstructive scalp flap transfer uses two types of flaps - pedicle flaps and free flaps.
Pedicle flaps are surgically removed from the donor site and transferred to the recipient site with an attached pedicle of tissues. This pedicle of tissues contains the flap’s artery-vein blood supply along with the flap tissues. The transfer of artery-vein blood supply along with the flap boosts the survival and health of the transferred tissue. Pedicle flaps are most often used for cosmetic hair restoration.
Free flaps are transferred from the donor site to the recipient site without any attached pedicle. But it must contain arteries and veins reattached to blood vessels at the recipient site by micro vascular surgery. These flaps are regularly used in reconstructive surgery when local skin is insufficient to raise a pedicle flap to cover a defect.
Risks of scalp flap transfer:
• Blood supply failure to the flap due to pressure on the flap’s blood supply that can result in partial or total loss of the flap.
• Nerve transaction during surgery that can cause loss of feeling over all or part of the scalp.
• Scarring at donor or recipient sites.
• Permanent hair loss at donor sites.
The discomfort of this operation is minimal. A dressing is worn for three to four days; no hair is cut during any of these procedures so the hair may be shampooed and styled immediately after dressings are removed. The stitches at the hairline are removed after six days; after ten to fourteen days, the stitches behind the Flap and on the side of the head are removed.
Advantages of scalp flap transfer:
• Excellent frontal scalp coverage
• Natural frontal hairline
• Excellent hair placement in temporal areas
• Good hair direction
• Avoidance of hair pattern distortion
These surgical procedures can be performed on an out-patient basis under either general or I.V. anesthesia.
Other Scalp Flap Transfer Procedures
All Skin Procedures
Scalp Flap Transfer BR (current)
Scalp Flap Transfer BR Chemical Peel
Scalp Flap Transfer BR Dermabrasion
Scalp Flap Transfer BR Laser Hair Removal
Scalp Flap Transfer BR Collagen Injections
More BR info...
Brazil Visa requirements
Citizens from Argentina, Bolivia, Chile, Paraguay, Peru and Uruguay may enter the country with a valid ID card and stay up to 90 days.
No visa is required for stays of up to 60 days from holders of passports from Venezuela.
No visa is required for stays of up to 90 days from holders of passports from Andorra, Argentina, Austria, Bahamas, Barbados, Belgium, Bolivia, Bulgaria, Chile, Colombia, Costa Rica, Croatia, Czech Rep., Denmark, Ecuador, Finland, France, Germany, Greece, Guatemala, Guyana, Honduras, Hong Kong, Hungary, Iceland, Ireland, Israel, Italy, South Korea, Liechtenstein, Luxembourg, Macau, Malaysia, Sovereign Military Order of Malta, Monaco, Morocco, Namibia, Netherlands, New Zealand, Norway, Panama, Paraguay, Peru, Philippines, Poland, Portugal, San Marino, Slovakia, Slovenia, South Africa, Spain, Suriname, Sweden, Switzerland, Thailand, Trinidad & Tobago, Tunisia, Turkey, Uruguay and Vatican City
Brazil By bus Long-distance bus service connects Brazil to its neighboring countries. The main capitals linked directly by bus are Buenos Aires, Asunci?n, Montevideo, Santiago de Chile, and Lima. Direct connections from the first three can also be found easily, but from Lima it might be tricky, though easily accomplished by changing at one of the others. Those typically go to S?o Paulo, though Pelotas has good connections too. It should be kept in mind that distances between S?o Paulo and any foreign capitals are significant.
The national land transport authority has listings[3] on all operating international bus lines.
Plastic Surgery News...
- The Healthy Communities Research Centre at UQ Ipswich is calling for a national focus on "health literacy" following the release of findings which reveal that most Australians don't have the basic knowledge to keep themselves healthy. The recently-released findings are based on the 2006 Adult Literacy and Life Skills survey conducted by the Australian Bureau of Statistics.
- Data presented at the American Society of Clinical Oncology meeting suggest that 15% of patients who took sunitinib (Sutent®) developed heart failure. Researchers studied 48 patients with kidney cancer or gastrointestinal stromal tumor (GIST) on sunitinib and noted that 7 (15%) experienced heart failure. The problems began between 22 days and 435 days after beginning therapy, although most started within the first three months of treatment. Individuals with a history of heart failure, coronary artery disease or low BMI were at an even higher risk and 3 of 5 patients followed long term continued to have heart problems even after the drug was stopped. The researchers call for routine cardiac monitoring in patients receiving sunitinib and for cardiac adverse effects to be carefully examined in future trials of the drug. Previously, a retrospective analysis of phase I/II data published in the Lancet had noted the development of cardiovascular adverse events, including heart failure, in some patients with GIST who took the drug (see NeLM link). At the time of the Lancet paper, Pfizer released a statement agreeing that these cardiac risks do exist but added that they "were medically manageable in most patients and underscore the importance of having a collaborative team of health-care professionals working together to appropriately manage patients who have limited available options" in treating their cancer.